1. Adult subjects between 18 and 65 years (both ages and sexes inclusive) who are confirmed to be positive for SARS-CoV2 by way of RT-PCR in a laboratory approved by MoH-FW and the State Government. <br/ >2. Subjects with co-morbidities can be included. To be analysed as cohort. <br/ >3. Subjects who are found to be Covid19 positive requiring hospitalization. (symptomatic or asymptomatic) <br/ >4. Subject and LAR who is willing to give informed consent for participation, able to comprehend and understand the responsibilities during treatment period. <br/ >5. Subjects who are willing not to participate in any other clinical trial during participation in the current trial. <br/ >

1. Adult subjects between 18 and 65 years (both ages and sexes inclusive) who are confirmed to be positive for SARS-CoV2 by way of RT-PCR in a laboratory approved by MoH-FW and the State Government. <br/ >2. Subjects with co-morbidities can be included. To be analysed as cohort. <br/ >3. Subjects who are found to be Covid19 positive requiring hospitalization. (symptomatic or asymptomatic) <br/ >4. Subject and LAR who is willing to give informed consent for participation, able to comprehend and understand the responsibilities during treatment period. <br/ >5. Subjects who are willing not to participate in any other clinical trial during participation in the current trial. <br/ >

1. Adult subjects between 18 and 65 years (both ages and sexes inclusive) who are confirmed to be positive for SARS-CoV2 by way of RT-PCR in a laboratory approved by MoH-FW and the State Government. <br/ >2. Subjects with co-morbidities can be included. To be analysed as cohort. <br/ >3. Subjects who are found to be Covid19 positive requiring hospitalization. (symptomatic or asymptomatic) <br/ >4. Subject and LAR who is willing to give informed consent for participation, able to comprehend and understand the responsibilities during treatment period. <br/ >5. Subjects who are willing not to participate in any other clinical trial during participation in the current trial. <br/ >

1. Adult subjects between 18 and 65 years (both ages and sexes inclusive) who are confirmed to be positive for SARS-CoV2 by way of RT-PCR in a laboratory approved by MoH-FW and the State Government. <br/ >2. Subjects with co-morbidities can be included. To be analysed as cohort. <br/ >3. Subjects who are found to be Covid19 positive requiring hospitalization. (symptomatic or asymptomatic) <br/ >4. Subject and LAR who is willing to give informed consent for participation, able to comprehend and understand the responsibilities during treatment period. <br/ >5. Subjects who are willing not to participate in any other clinical trial during participation in the current trial. <br/ >